{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:49:48Z","timestamp":1790419788755,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008537","name":"Benign Essential Blepharospasm Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001288","name":"Parkinson's Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013928","name":"National Spasmodic Dysphonia Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008771","name":"Tourette Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008440","name":"International Parkinson and Movement Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["TR 001456"],"award-info":[{"award-number":["TR 001456"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS116025"],"award-info":[{"award-number":["NS116025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS065701"],"award-info":[{"award-number":["NS065701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017876","name":"American Dystonia Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010987","name":"American Neurological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020036","name":"Dystonia Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ncl.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:39:36Z","timestamp":1583167176000},"page":"325-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Medical and Surgical Treatments for Dystonia"],"prefix":"10.1016","volume":"38","author":[{"given":"H.A.","family":"Jinnah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2020.01.003_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41572-018-0023-6","article-title":"Dystonia","volume":"4","author":"Balint","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ncl.2020.01.003_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mdc3.12100","article-title":"The new classification for the dystonias: why was it needed and how was it accomplished?","volume":"1","author":"Jinnah","year":"2014","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.ncl.2020.01.003_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.25549","article-title":"Assessment of the patient with dystonia: an update on dystonia syndromes","volume":"28","author":"Fung","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nbd.2019.05.014","article-title":"Dystonia genes and their biological pathways","volume":"129","author":"Jinnah","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.ncl.2020.01.003_bib6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/CON.0000000000000747","article-title":"The dystonias","volume":"25","author":"Jinnah","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.ncl.2020.01.003_bib7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/ene.13731","article-title":"Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia","volume":"25","author":"Esposito","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/mds.26817","article-title":"Clinical and demographic characteristics related to onset site and spread of cervical dystonia","volume":"31","author":"Norris","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clineuro.2015.02.015","article-title":"The spread of primary late-onset focal dystonia in a long-term follow up study","volume":"132","author":"Svetel","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ncl.2020.01.003_bib10","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/mds.25088","article-title":"Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia","volume":"27","author":"Martino","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib11","first-page":"879","article-title":"Spread of primary dystonia in relation to initially affected region","volume":"254","author":"Svetel","year":"2007","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20919","article-title":"Relative risk of spread of symptoms among the focal onset primary dystonias","volume":"21","author":"Weiss","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jnnp.2007.124594","article-title":"Long-term assessment of the risk of spread in primary late-onset focal dystonia","volume":"79","author":"Abbruzzese","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ncl.2020.01.003_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jamaoto.2018.0644","article-title":"Consensus-based attributes for identifying patients with spasmodic dysphonia and other voice disorders","volume":"144","author":"Ludlow","year":"2018","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ncl.2020.01.003_bib15","article-title":"Clinical diagnostic exome sequencing in dystonia: genetic testing challenges for complex conditions","author":"Powis","year":"2019","journal-title":"Clin Genet"},{"key":"10.1016\/j.ncl.2020.01.003_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jocn.2014.09.014","article-title":"Diagnostic delay in adult-onset dystonia: data from an Italian movement disorder center","volume":"22","author":"Macerollo","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2020.01.003_bib17","first-page":"592","article-title":"Diagnostic delays in spasmodic dysphonia: a call for clinician education","volume":"29","author":"Creighton","year":"2015","journal-title":"J\u00a0Voice"},{"key":"10.1016\/j.ncl.2020.01.003_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jocn.2015.05.054","article-title":"Delays to the diagnosis of cervical dystonia","volume":"25","author":"Bertram","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2020.01.003_bib19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2013.08.028","article-title":"How long does it take to diagnose cervical dystonia?","volume":"335","author":"Tiderington","year":"2013","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2020.01.003_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/mds.25501","article-title":"Psychiatric comorbidities in dystonia: emerging concepts","volume":"28","author":"Zurowski","year":"2013","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.ncl.2020.01.003_bib21","first-page":"1857","article-title":"The effectiveness of physiotherapy for cervical dystonia: a systematic literature review","volume":"261","author":"De Pauw","year":"2014","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mdc3.12574","article-title":"Systematic review of rehabilitation in focal dystonias: classification and recommendations","volume":"5","author":"Prudente","year":"2018","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.ncl.2020.01.003_bib23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.parkreldis.2012.04.027","article-title":"Prevalence, predictors, and perceived effectiveness of complementary, alternative and integrative medicine in adult-onset primary dystonia","volume":"18","author":"Fleming","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/mds.25552","article-title":"Medical treatment of dystonia","volume":"28","author":"Jankovic","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000003596","article-title":"Dystonia treatment: patterns of medication use in an international cohort","volume":"88","author":"Pirio Richardson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.01.003_bib26","first-page":"77","article-title":"Diagnosis and treatment of dystonia","volume":"vol. 33","author":"Jinnah","year":"2015"},{"key":"10.1016\/j.ncl.2020.01.003_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13311-013-0231-4","article-title":"Treatment of dystonia","volume":"11","author":"Thenganatt","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ncl.2020.01.003_bib28","first-page":"547","article-title":"Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia","volume":"50","author":"Greene","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejpn.2016.02.003","article-title":"Medication use in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1468-1331.2006.01537.x","article-title":"A\u00a0systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS\/MDS-ES task force","volume":"13","author":"Albanese","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1468-1331.2004.00845.x","article-title":"Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options","volume":"11","author":"Balash","year":"2004","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00002826-199208000-00002","article-title":"Baclofen in the treatment of dystonia","volume":"15","author":"Greene","year":"1992","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2020.01.003_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.25498","article-title":"The effect of intrathecal baclofen in dyskinetic cerebral palsy: the IDYS trial","volume":"86","author":"Bonouvrie","year":"2019","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2020.01.003_bib34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00228-019-02744-8","article-title":"Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review","volume":"75","author":"Andre","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ncl.2020.01.003_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/dmcn.13652","article-title":"Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review","volume":"60","author":"Fehlings","year":"2018","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2020.01.003_bib36","article-title":"Trihexyphenidyl for dystonia in cerebral palsy","author":"Harvey","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2020.01.003_bib37","first-page":"365","article-title":"Choosing a skeletal muscle relaxant","volume":"78","author":"See","year":"2008","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ncl.2020.01.003_bib38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","article-title":"Dopa-responsive dystonia--clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11910-014-0461-9","article-title":"Clinical spectrum of dopa-responsive dystonia and related disorders","volume":"14","author":"Lee","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ncl.2020.01.003_bib40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(11)70141-7","article-title":"The monoamine neurotransmitter disorders: an expanding range of neurological syndromes","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib41","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1212\/WNL.0b013e3182a55fa2","article-title":"Ataxia telangiectasia presenting as dopa-responsive cervical dystonia","volume":"81","author":"Charlesworth","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.01.003_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-510X(03)00129-1","article-title":"Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family","volume":"213","author":"Wilder-Smith","year":"2003","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2020.01.003_bib43","first-page":"561","article-title":"Dopamine agonists and antagonists in the treatment of idiopathic dystonia","volume":"50","author":"Lang","year":"1988","journal-title":"Adv Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/jpet.117.246348","article-title":"Dopamine receptor agonist treatment of idiopathic dystonia: a reappraisal in humans and mice","volume":"365","author":"Fan","year":"2018","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ncl.2020.01.003_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1474-4422(14)70190-5","article-title":"Wilson's disease and other neurological copper disorders","volume":"14","author":"Bandmann","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MPG.0000000000001102","article-title":"Controversies and variation in diagnosing and treating children with Wilson disease: results of an international survey","volume":"63","author":"Sturm","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ncl.2020.01.003_bib47","doi-asserted-by":"crossref","first-page":"11601","DOI":"10.1038\/ncomms11601","article-title":"Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia","volume":"7","author":"Tuschl","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ncl.2020.01.003_bib48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ajhg.2012.01.018","article-title":"Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man","volume":"90","author":"Tuschl","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2020.01.003_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ajhg.2012.01.017","article-title":"Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease","volume":"90","author":"Quadri","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ncl.2020.01.003_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mds.27140","article-title":"Treatable inherited rare movement disorders","volume":"33","author":"Jinnah","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2020.01.003_bib52","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/mds.25011","article-title":"Movement disorders in autoimmune diseases","volume":"27","author":"Baizabal-Carvallo","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2377-14-91","article-title":"Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia","volume":"14","author":"Marsh","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib54","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.01.003_bib55","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ncl.2020.01.003_bib56","article-title":"Botulinum toxin type A therapy for cervical dystonia","author":"Castelao","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2020.01.003_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"Hallett","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.ncl.2020.01.003_bib58","series-title":"Manual of botulinum toxin","author":"Truong","year":"2009"},{"key":"10.1016\/j.ncl.2020.01.003_bib59","series-title":"Pictoral atlas of botulinum toxin injection: dosage, localization, application","author":"Jost","year":"2008"},{"issue":"8","key":"10.1016\/j.ncl.2020.01.003_bib60","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/mds.27072","article-title":"Botulinum toxin: state of the art","volume":"32","author":"Jankovic","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib61","first-page":"1188","article-title":"Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes","volume":"263","author":"Jinnah","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2014.09.034","article-title":"Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia","volume":"21","author":"Ferreira","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib63","first-page":"1932","article-title":"A\u00a0strategy for managing flu-like symptoms after botulinum toxin injections","volume":"265","author":"George","year":"2018","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10072-013-1526-2","article-title":"The combined treatment with orbital and pretarsal botulinum toxin injections in the management of poorly responsive blepharospasm","volume":"35","author":"Esposito","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ncl.2020.01.003_bib65","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13760-012-0019-z","article-title":"Combination of blepharospasm and apraxia of eyelid opening: a condition resistant to treatment","volume":"112","author":"Rana","year":"2012","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.ncl.2020.01.003_bib66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/jnnp.59.3.309","article-title":"Pretarsal application of botulinum toxin for treatment of blepharospasm","volume":"59","author":"Aramideh","year":"1995","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2020.01.003_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2054-7072-1-3","article-title":"The phenomenology and natural history of idiopathic lower cranial dystonia","volume":"1","author":"Termsarasab","year":"2014","journal-title":"J\u00a0Clin Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5334\/tohm.194","article-title":"Clinical, etiological, and therapeutic features of jaw-opening and jaw-closing oromandibular dystonias: a decade of experience at a single treatment center","volume":"4","author":"Gonzalez-Alegre","year":"2014","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.ncl.2020.01.003_bib69","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s13311-018-0620-9","article-title":"Pilot single-blind trial of abobotulinumtoxinA in oromandibular dystonia","volume":"15","author":"Scorr","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ncl.2020.01.003_bib70","first-page":"1702","article-title":"Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue","volume":"263","author":"Nastasi","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jocn.2014.08.027","article-title":"Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach","volume":"22","author":"Moscovich","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2020.01.003_bib72","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.23504","article-title":"Long-term follow-up of botulinum toxin therapy for focal hand dystonia: outcome at 10 years or more","volume":"26","author":"Lungu","year":"2011","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2020.01.003_bib73","article-title":"Botulinum toxin injections for the treatment of spasmodic dysphonia","author":"Watts","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2020.01.003_bib74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0003489415588557","article-title":"The Mayo Clinic Arizona spasmodic dysphonia experience: a demographic analysis of 718 patients","volume":"124","author":"Patel","year":"2015","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ncl.2020.01.003_bib75","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/lary.25273","article-title":"Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients","volume":"125","author":"Blitzer","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ncl.2020.01.003_bib76","article-title":"Deep brain stimulation in pediatric dystonia: a systematic review","author":"Hale","year":"2018","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.ncl.2020.01.003_bib77","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14737175.2018.1478288","article-title":"Surgical treatment of dystonia","volume":"18","author":"Cury","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.ncl.2020.01.003_bib78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.26890","article-title":"Current applications and limitations of surgical treatments for movement disorders","volume":"32","author":"Krack","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib79","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1212\/WNL.0000000000001312","article-title":"Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia","volume":"84","author":"Bruggemann","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.01.003_bib80","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00702-016-1656-9","article-title":"Deep brain stimulation for dystonia: a novel perspective on the value of genetic testing","volume":"124","author":"Jinnah","year":"2017","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"Suppl 1","key":"10.1016\/j.ncl.2020.01.003_bib81","first-page":"S54","article-title":"Long-term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations","volume":"26","author":"Tagliati","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib82","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1474-4422(12)70257-0","article-title":"Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial","volume":"11","author":"Volkmann","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib83","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mds.23549","article-title":"Long-term clinical outcome in Meige syndrome treated with internal pallidum deep brain stimulation","volume":"26","author":"Reese","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib84","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1227\/01.neu.0000429841.84083.c8","article-title":"Deep brain stimulation in DYT1 dystonia: a 10-year experience","volume":"73","author":"Panov","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ncl.2020.01.003_bib85","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1212\/WNL.0000000000006818","article-title":"Safety and long-term efficacy of ventro-oral thalamotomy for focal hand dystonia: a retrospective study of 171 patients","volume":"92","author":"Horisawa","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.01.003_bib86","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23877","article-title":"Long-term improvement of musician's dystonia after stereotactic ventrooralthalamotomy","volume":"74","author":"Horisawa","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamaneurol.2017.3129","article-title":"A\u00a0review of the current therapies, challenges, and future directions of transcranial focused ultrasound technology: advances in diagnosis and treatment","volume":"75","author":"Krishna","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib88","first-page":"300","article-title":"Selective peripheral denervation: comparison with pallidal stimulation and literature review","volume":"261","author":"Contarino","year":"2014","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib89","doi-asserted-by":"crossref","first-page":"e940","DOI":"10.1016\/j.wneu.2018.10.178","article-title":"Deep brain stimulation versus peripheral denervation for cervical dystonia: a systematic review and meta-analysis","volume":"122","author":"Ravindran","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ncl.2020.01.003_bib90","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajo.2007.10.017","article-title":"Upper eyelid myectomy in blepharospasm with associated apraxia of lid opening","volume":"145","author":"Georgescu","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ncl.2020.01.003_bib91","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.IOP.0000162429.97307.4D","article-title":"Assessment of blepharospasm surgery using an improved disability scale: study of 138 patients","volume":"21","author":"Grivet","year":"2005","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ncl.2020.01.003_bib92","first-page":"488","article-title":"Myectomy for blepharospasm 2013","volume":"24","author":"Pariseau","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ncl.2020.01.003_bib93","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MOO.0b013e32832aef6f","article-title":"Treatment for spasmodic dysphonia: limitations of current approaches","volume":"17","author":"Ludlow","year":"2009","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ncl.2020.01.003_bib94","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.otohns.2008.05.624","article-title":"Research priorities in spasmodic dysphonia","volume":"139","author":"Ludlow","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ncl.2020.01.003_bib95","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxicon.2017.09.004","article-title":"Longitudinal studies of botulinum toxin in cervical dystonia: why do patients discontinue therapy?","volume":"147","author":"Jinnah","year":"2018","journal-title":"Toxicon"},{"issue":"9","key":"10.1016\/j.ncl.2020.01.003_bib96","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/17460441.2019.1623785","article-title":"New approaches to discovering drugs that treat dystonia","volume":"14","author":"Pirio Richardson","year":"2019","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.ncl.2020.01.003_bib97","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ncl.2020.01.003_bib98","doi-asserted-by":"crossref","first-page":"104579","DOI":"10.1016\/j.nbd.2019.104579","article-title":"Dystonia and levodopa-induced dyskinesias in Parkinson's disease: is there a connection?","volume":"132","author":"Calabresi","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.ncl.2020.01.003_bib99","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/cge.13057","article-title":"On the complexity of clinical and molecular bases of neurodegeneration with brain iron accumulation","volume":"93","author":"Tello","year":"2018","journal-title":"Clin Genet"},{"key":"10.1016\/j.ncl.2020.01.003_bib100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","article-title":"Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study","volume":"18","author":"Klopstock","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2020.01.003_bib101","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1212\/WNL.0000000000006688","article-title":"High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy","volume":"92","author":"Albrecht","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2020.01.003_bib102","first-page":"105","article-title":"Neutralizing antibody and Botulinum toxin therapy: a systematic review and meta-analysis","volume":"25","author":"Fabbri","year":"2015","journal-title":"Neurotox Res"},{"key":"10.1016\/j.ncl.2020.01.003_bib103","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.parkreldis.2013.01.018","article-title":"Cervical dystonia: improved treatment response to botulinum toxin after referral to a tertiary centre and the use of polymyography","volume":"19","author":"Nijmeijer","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib104","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/mds.21051","article-title":"Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test","volume":"21","author":"Cordivari","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2020.01.003_bib105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5334\/tohm.185","article-title":"Botulinum toxin therapy for cervical dystonia: the science of dosing","volume":"4","author":"Evidente","year":"2014","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"10.1016\/j.ncl.2020.01.003_bib106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.toxicon.2015.09.037","article-title":"Is it time for flexibility in botulinum inter-injection intervals?","volume":"107","author":"Ojo","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.ncl.2020.01.003_bib107","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/CPJ.0000000000000568","article-title":"Management of cervical dystonia with botulinum neurotoxins and EMG\/ultrasound guidance","volume":"9","author":"Castagna","year":"2019","journal-title":"Neurol Clin Pract"},{"issue":"12","key":"10.1016\/j.ncl.2020.01.003_bib108","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/jnnp-2017-317098","article-title":"Physiological effects of subthalamic nucleus deep brain stimulation surgery in cervical dystonia","volume":"89","author":"Wagle Shukla","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2020.01.003_bib109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.brs.2017.11.015","article-title":"Effects of cerebellar neuromodulation in movement disorders: a systematic review","volume":"11","author":"Franca","year":"2018","journal-title":"Brain Stimul"},{"key":"10.1016\/j.ncl.2020.01.003_bib110","first-page":"1","article-title":"The striking effects of deep cerebellar stimulation on generalized fixed dystonia: case report","author":"Horisawa","year":"2019","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ncl.2020.01.003_bib111","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fnins.2017.00423","article-title":"Therapeutic use of non-invasive brain stimulation in dystonia","volume":"11","author":"Quartarone","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ncl.2020.01.003_bib112","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2019.02.020","article-title":"Remission in dystonia - Systematic review of the literature and meta-analysis","volume":"66","author":"Mainka","year":"2019","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:03:17Z","timestamp":1778752997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0733861920300037"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.01.003","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical and Surgical Treatments for Dystonia","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}